Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · IEX Real-Time Price · USD
37.75
+0.99 (2.69%)
At close: Aug 8, 2022 4:00 PM
38.00
+0.25 (0.66%)
After-hours:
Aug 8, 2022 7:41 PM EDT
Ratios and Metrics (Annual)
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | Current | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|
Market Capitalization
|
1,843 | 1,114 | 955 | 905 | 917 | 885 | 848 | 641 | 518 |
Market Cap Growth
|
- | 16.65% | 5.51% | -1.30% | 3.71% | 4.34% | 32.33% | 23.58% | - |
Enterprise Value
|
1,759 | 1,080 | 913 | 883 | 874 | 859 | 811 | 614 | 493 |
PE Ratio
|
23.59 | 17.94 | 680.90 | 18.50 | -159.87 | 242.55 | 86.33 | -229.86 | -48.45 |
PS Ratio
|
4.05 | 2.55 | 2.73 | 2.81 | 3.11 | 3.68 | 3.32 | 2.55 | 2.46 |
PB Ratio
|
3.84 | 2.50 | 2.38 | 2.37 | 2.76 | 2.65 | 2.58 | 2.17 | 1.84 |
P/FCF Ratio
|
18.44 | 15.80 | 40.81 | 4.00 | - | 215.22 | 49.35 | - | 937.38 |
P/OCF Ratio
|
14.64 | 11.37 | 16.68 | 21.68 | 24.02 | 22.56 | 21.99 | 59.98 | 24.62 |
EV/Sales Ratio
|
3.87 | 2.54 | 2.66 | 2.74 | 3.04 | 3.61 | 3.23 | 2.44 | 2.35 |
EV/EBITDA Ratio
|
13.39 | 10.21 | 31.63 | 10.66 | 155.28 | 57.63 | 29.62 | 317.39 | - |
EV/EBIT Ratio
|
16.59 | 13.32 | 175.24 | 14.07 | - | 417.40 | 52.63 | - | - |
EV/FCF Ratio
|
17.60 | 15.79 | 39.80 | 4.00 | - | 210.73 | 47.96 | - | 895.74 |
Debt / Equity Ratio
|
0.22 | 0.23 | 0.17 | 0.17 | 0.15 | 0.14 | 0.11 | 0.14 | 0.16 |
Debt / EBITDA Ratio
|
0.80 | 0.96 | 2.28 | 0.80 | 8.71 | 3.14 | 1.36 | 21.22 | -8.72 |
Debt / FCF Ratio
|
1.05 | 1.48 | 2.87 | 321.86 | -6.00 | 11.47 | 2.20 | -7.73 | 79.02 |
Current Ratio
|
3.19 | 3.06 | 2.49 | 2.84 | 2.06 | 2.80 | 3.04 | 2.93 | 3.16 |
Asset Turnover
|
0.67 | 0.67 | 0.58 | 0.56 | 0.62 | 0.54 | 0.62 | 0.64 | 0.55 |
Return on Equity (ROE)
|
18.30% | 14.60% | 0.40% | 13.10% | -1.80% | 1.10% | 3.10% | -1.00% | -3.90% |
Return on Assets (ROA)
|
12.00% | 9.40% | 0.20% | 8.40% | -1.20% | 0.80% | 2.40% | -0.70% | -2.80% |
Return on Capital (ROIC)
|
21.60% | 17.60% | 1.20% | 15.10% | -2.70% | 0.70% | 5.60% | -3.60% | -6.70% |
Earnings Yield
|
4.41% | 5.57% | 0.15% | 5.41% | -0.63% | 0.41% | 1.16% | -0.43% | -2.06% |
FCF Yield
|
5.42% | 6.33% | 2.45% | 0.02% | -0.91% | 0.46% | 2.03% | -0.83% | 0.11% |
Buyback Yield / Dilution
|
-4.97% | -1.34% | 1.57% | -7.57% | 4.08% | -1.82% | -5.66% | -7.16% | -7.91% |
Total Shareholder Return
|
-4.97% | -1.34% | 1.57% | -7.57% | 4.08% | -1.82% | -5.66% | -7.16% | -7.91% |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).